Gene Editing Service Market Growth Opportunities and Forecast by 2031

The Gene Editing Service Market is expected to register a CAGR of 10.4% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The Gene Editing Service Market report covers analysis by Technology (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nuclease (TALEN), Zinc Finger Nuclease (ZFN), Other Technologies); Application (Cell Line Editing, Animal Genome Editing, Plant Genome Editing, Others); End-User (Pharmaceutical Companies And Biotechnology Companies, Academics And Government Research Institutes, Clinical Research Organizations), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.

Purpose of the Report

The report Gene Editing Service Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

• Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
• Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
• Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Gene Editing Service Market Segmentation

Technology

• Clustered Regularly Interspaced Short Palindromic Repeats
• Transcription Activator-Like Effector Nuclease
• Zinc Finger Nuclease

Application

• Cell Line Editing
• Animal Genome Editing
• Plant Genome Editing

End-User

• Pharmaceutical Companies And Biotechnology Companies
• Academics And Government Research Institutes
• Clinical Research Organizations

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Gene Editing Service Market Growth Drivers

• Advances in CRISPR Technology: The introduction of CRISPR-Cas9 has revolutionized gene editing due to its simplicity, precision, and cost-effectiveness. This technology allows for more efficient gene modifications compared to older methods such as TALENs and ZFNs. CRISPR technology has gained widespread acceptance in research and therapy, driving demand for gene editing services. The continuous advancements and refinements in CRISPR technology, including CRISPR-based gene therapies, are fueling growth in the gene editing service market.
• Increasing Demand for Precision Medicine: As health care moves towards precision medicine, there is an increasing need for gene editing to provide tailored treatments. Gene editing technologies are part of the therapies tailored to an individual's genetic makeup, especially in the treatment of genetic disorders like sickle cell anemia, cystic fibrosis, and Duchenne muscular dystrophy. This is what has increased the demand for gene editing services in clinical applications, including gene therapy and cell-based therapies.
• Investments in Genetic Research and Biotechnology: Strong investment in genetic research and biotechnology is driving gene editing technologies and services. Today, research organizations, biotechnology companies, and pharmaceutical companies are also investing more in the exploration of gene editing prospects in gene therapy, oncology, and other inherited diseases. In June 2024, GenKOre from South Korea collaborated with Revvity from the United States to work on gene therapies for ocular disorders. GenKOre's TaRGET platform would be coupled with the vectors developed by Revvity to pursue in vivo gene editing for Leber Congenital Amaurosis 10 and Usher Syndrome Type 2A. The growth in private and public funding for genetic research is fostering the growth of the gene editing service market.

Gene Editing Service Market Future Trends

• Integration of gene editing with stem cell therapy: One of the most significant trends in the gene editing service market is the integration of gene editing techniques with stem cell therapy. Gene editing can be used to modify stem cells before they are used in therapies for treating genetic diseases, cancer, and autoimmune disorders. Combining gene editing with stem cell-based treatments offers the potential for more effective, personalized treatments for a wide range of conditions, including genetic mutations and tissue regeneration.
• Expansion in Agricultural Biotechnology: It plays a more dominant role in agricultural biotechnology today as it develops gene editing in application areas including improvement of crops, and pest and disease resistance. More and more genetically modified crops and livestock will come into use using gene editing services to further develop food security and nutritional enhancement besides reducing impacts on the environment. The urgent interest in developing a sustainable system for farming in this world demands a climate-resistance crop as one of the results of applying gene editing in this industry.
• Use of Gene Editing in Disease Modeling: The demand for gene editing services to develop disease models in research applications is increasing. Researchers can achieve more precise models of human diseases by adding a specific genetic mutation to a laboratory animal. These models are crucial for drug development, toxicology testing, and disease mechanism studies. In May 2024, Merck KGaA (Germany) acquired Mirus Bio, Inc. (US), integrating Mirus Bio's transfection technology with Merck's bioprocessing expertise. This acquisition, completed enhanced Merck's capabilities in viral vector manufacturing, advancing support for cell and gene therapies. Thus, the rising demand for gene-edited models in pharmaceutical and biotechnological drug discovery and preclinical research is creating demand for gene-editing services.

Gene Editing Service Market Opportunities

• Development of New Genomic Editing Instruments: Such developments will continue offering opportunities for building next-generation tools for genetic editing that are of higher precision and efficiency and can be safer for use. This will give such companies an upper hand in their endeavors when it comes to market competition. Agilent Technologies, Inc. in the United States acquired BIOVECTRA, Inc. (Canada) in July 2024. Its biopharma solutions were extended by the strength of BIOVECTRA's expertise in biologics and gene editing. Thus, Agilent's drug development and manufacturing capabilities would be expanded. Innovations in gene-editing tools are likely to break new grounds regarding safer and more efficient gene modifications; this will usher in new uses and further contribute to the expanding gene editing services market.
• Strategic Partnerships and Collaborations: Collaboration between biotech firms, pharmaceutical companies, academic institutions, and research organizations presents a significant opportunity for expanding gene editing services. By partnering with leaders in drug development and clinical research, gene editing service providers can expand their reach, access new technologies, and participate in large-scale clinical trials. In March 2023, GenScript (US) announced a strategic collaboration with PersonGen-Anke Cellular Therapeutics (US) to advance cell isolation products. The collaboration aimed to enhance the efficiency of developing and producing cell therapy. GenScript's CytoSinct platform was expected to support PersonGen in reducing costs and improving R&D efficiency in cell therapy. Strategic partnerships can accelerate the development of new therapies and increase the market visibility of gene editing services.
• Gene Editing for Agriculture and Food Security: The demand for sustainable food production methods is creating a strong opportunity for gene editing services in the agricultural sector. Gene editing can revolutionize food production systems by improving crop yields, resistance to pests, and environmental stress tolerance. Agricultural gene editing services that focus on genetically modified crops or livestock to meet the growing global demand for food are likely to experience significant market growth, particularly in regions facing food security challenges.

Gene Editing Service Market Regional Insights

The regional trends and factors influencing the Gene Editing Service Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Gene Editing Service Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Gene Editing Service Market Report Scope

Gene Editing Service Market Players Density: Understanding Its Impact on Business Dynamics

The Gene Editing Service Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Gene Editing Service Market are:

1. GenScript USA Inc.
2. Horizon Discovery Group plc
3. Integrated DNA Technologies Inc.
4. Lonza Group Ltd
5. Merck & Co.
6. New England Biolabs Inc.

Disclaimer: The companies listed above are not ranked in any particular order.

Key Selling Points

• Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Gene Editing Service Market, providing a holistic landscape.
• Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
• Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
• Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Gene Editing Service Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.